<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02937207</url>
  </required_header>
  <id_info>
    <org_study_id>LH20161013</org_study_id>
    <nct_id>NCT02937207</nct_id>
  </id_info>
  <brief_title>Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine</brief_title>
  <official_title>Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai University of Traditional Chinese Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the clinical efficacy of traditional Chinese
      medicine in the treatment of asthma, and to promote the application in community hospitals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Asthma is a serious global health problem and has increasing prevalence in many
      countries.Although asthma symptoms can be controlled by drug treatment to a large extent,
      there is still inadequate.Traditional Chinese medicine has a long history of treating asthma,
      and has a good clinical curative effect.The purpose of this study is to evaluate the clinical
      efficacy of traditional Chinese medicine in the treatment of asthma, and to promote the
      application in community hospitals. This could constitute a significant advance in asthma
      management.

      In this study, the investigators recruited patients with asthma exacerbation and remission
      stage, and gave the corresponding western medicine background treatment and traditional
      Chinese medicine treatment program.Participants will undergo a physical examination, lung
      function, blood and sputum collection.

      Exacerbation group belongs to cold type of asthma patients will take Ke Chuan Liu Wei
      Mixture, wind phlegm type of asthma patients will take Chuan Xiong Ping Chuan Mixture and Xie
      Wu Capsuleï¼Œand hot type of asthma patients will take Dan Ma Jia Tablet for 14 days treatment,
      while the 3 control groups were given 3 corresponding placebo treatment for a total of 14
      days.

      Remission phase of Yang deficiency patients in treatment group will take Zhi Chuan Capsule
      and Bu Shen Na Qi Granule, and in control group received a placebo treatment for a total of
      60 days.

      Study visits will occur for 7 days of exacerbation group and 1 year for remission group.
      Questionnaires to assess asthma control will be completed during study of asthma at
      exacerbation stage within 44 days and on remission period within 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 30, 2018</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Asthma control rate</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Asthma control rate will be measured during study of asthma at exacerbation stage within 44 days and symptom-free months will be measured on remission period within 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung function(FEV1, PVC, PEF)</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Measured during study of asthma at exacerbation stage within 44 days and on remission period within 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of the fractional concentration of exhaled nitric oxide</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Measured during study of asthma at exacerbation stage within 44 days and on remission period within 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood routine examination</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Measured during study of asthma at exacerbation stage within 44 days and on remission period within 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cytokine levels of serum and induced sputum</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Measured during study of asthma at exacerbation stage within 44 days and on remission period within 12 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver function test</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Measured Liver function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kidney function test</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Measured Kidney function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T cell classification</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Measured T cell classification of PBMC</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cytokine levels of induced sputum</measure>
    <time_frame>up to 12 months</time_frame>
    <description>Measured cytokine levels of induced sputum supernatant</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">288</enrollment>
  <condition>Bronchial Asthma</condition>
  <arm_group>
    <arm_group_label>Hanxiao treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>36 patients of exacerbation group belongs to cold type of asthma will take Ke Chuan Liu Wei Mixture oral therapy twice everyday for 14 days and background therapy of ICS and beta2-agonist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hanxiao control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>36 patients of exacerbation group belongs to cold type of asthma will take Ke Chuan Liu Wei Mixture placebo oral therapy twice everyday for 14 days and background therapy of ICS and beta2-agonist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fengtanxiao treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>36 patients of exacerbation group belongs to wind phlegm type of asthma will take Chuan Xiong Ping Chuan Mixture and Xie Wu Capsule oral therapy twice everyday for 14 days and background therapy of ICS and beta2-agonist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fengtanxiao control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>36 patients of exacerbation group belongs to wind phlegm type of asthma will take Chuan Xiong Ping Chuan Mixture placebo and Xie Wu Capsule placebo oral therapy twice everyday for 14 days and background therapy of ICS and beta2-agonist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rexiao treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>36 patients of exacerbation group belongs to hot type of asthma will take Dan Ma Jia Tablet oral therapy thrice everyday for 14 days and background therapy of ICS and beta2-agonist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rexiao control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>36 patients of exacerbation group belongs to hot type of asthma will take Dan Ma Jia Tablet placebo oral therapy thrice everyday for 14 days and background therapy of ICS and beta2-agonist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xuxiao treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>36 patients of remission phase of Yang deficiency of asthma will take Zhi Chuan Capsule and Bu Shen Na Qi Granule oral therapy thrice everyday for 14 days and background therapy of ICS and beta2-agonist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Xuxiao control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>36 patients of remission phase of Yang deficiency of asthma will take Zhi Chuan Capsule placebo and Bu Shen Na Qi Granule placebo oral therapy thrice everyday for 14 days and background therapy of ICS and beta2-agonist.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ke Chuan Liu Wei Mixture</intervention_name>
    <description>Experience formula of famous traditional Chinese professor Yingen Wu</description>
    <arm_group_label>Hanxiao treatment group</arm_group_label>
    <other_name>Ke Chuan Liu Wei He Ji</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chuan Xiong Ping Chuan Mixture</intervention_name>
    <description>Experience formula of famous traditional Chinese professor Changrong Shao</description>
    <arm_group_label>Fengtanxiao treatment group</arm_group_label>
    <other_name>Chuan Xiong Ping Chuan He Ji</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xie Wu Capsule</intervention_name>
    <description>Experience formula of famous traditional Chinese professor Jianhua Hu</description>
    <arm_group_label>Fengtanxiao treatment group</arm_group_label>
    <other_name>Xie Wu Jiao Nang</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dan Ma Jia Tablet</intervention_name>
    <description>Experience formula of famous traditional Chinese professor Xiaopu Xu</description>
    <arm_group_label>Rexiao treatment group</arm_group_label>
    <other_name>Dan Ma Jia Pian</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zhi Chuan Capsule</intervention_name>
    <description>Experience formula of famous traditional Chinese professor Yingen Wu</description>
    <arm_group_label>Xuxiao treatment group</arm_group_label>
    <other_name>Zhi Chuan Jiao Nang</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bu Shen Na Qi Granule</intervention_name>
    <description>Experience formula of famous traditional Chinese professor Changrong Shao</description>
    <arm_group_label>Xuxiao treatment group</arm_group_label>
    <other_name>Bu Shen Na Qi Ke Li</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ke Chuan Liu Wei Mixture placebo</intervention_name>
    <description>Low dose combination for treating prescription of Ke Chuan Liu Wei Mixture</description>
    <arm_group_label>Hanxiao control group</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chuan Xiong Ping Chuan Mixture placebo</intervention_name>
    <description>Low dose combination for treating prescription of Chuan Xiong Ping Chuan Mixture</description>
    <arm_group_label>Fengtanxiao control group</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xie Wu Capsule placebo</intervention_name>
    <description>Low dose combination for treating prescription of Xie Wu Capsule</description>
    <arm_group_label>Fengtanxiao control group</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dan Ma Jia Tablet placebo</intervention_name>
    <description>Low dose combination for treating prescription of Dan Ma Jia Tablet</description>
    <arm_group_label>Rexiao control group</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zhi Chuan Capsule placebo</intervention_name>
    <description>Low dose combination for treating prescription of Zhi Chuan Capsule</description>
    <arm_group_label>Xuxiao control group</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bu Shen Na Qi Granule placebo</intervention_name>
    <description>Low dose combination for treating prescription of Bu Shen Na Qi Granule</description>
    <arm_group_label>Xuxiao control group</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients had positive bronchodilator reversibility test or positive bronchial
             challenge test or more than 50 parts per billion of FENO before

          -  Number of months without control between 1 and 3 months last year

          -  The course of asthma was more than 10 years and less than 30 years

          -  Conform to the predetermined 4 TCM Syndrome Types

          -  Patients who have given written informed consent

        Exclusion Criteria:

          -  Smoking and continuous exposure to hazardous environment

          -  With fever, or severity of intermittent state, high degree of sustained, or with
             respiratory failure, etc.

          -  Long term inhaled corticosteroids (more than 5 years) prior to study entry

          -  Pulmonary emphysema, chronic obstructive pulmonary disease, pulmonary emphysema,
             pulmonary heart disease, pneumonia, lung cancer and other lung diseases

          -  Rheumatic immune disease, diabetes, hyperthyroidism, menopause, gastroesophageal
             reflux, arrhythmia and other complications of the disease

          -  Heart, liver, kidney and other organ dysfunction

          -  Accompanied by other diseases of long-term use of glucocorticoids, anti allergy drugs,
             mental or neurological drugs or traditional Chinese Medicine

          -  Patients who are allergic to therapeutic medicine

          -  Female patients in lactation period, pregnancy or planning to get pregnant during the
             trial

          -  Patients with mental or neurological disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhenhui Lu, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Longhua Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zifeng Ma, Master</last_name>
    <phone>+8602164385700</phone>
    <phone_ext>1307</phone_ext>
    <email>mzf05@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shaoyan Zhang, Doctor</last_name>
    <phone>+8602164385700</phone>
    <phone_ext>1307</phone_ext>
    <email>475205883@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fenglin Street Community Health Service Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chuntao Yi, Master</last_name>
      <phone>+8618817338803</phone>
      <email>yichuntao@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kangjian Street Community Health Service Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Taiquan Huang, Master</last_name>
      <phone>+8613918375404</phone>
      <email>tqh957@sina.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianping Street Community Health Service Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xin He, Master</last_name>
      <phone>+8613501903509</phone>
      <email>hexin2050@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Longhua Hospital Affiliated Shanghai University of TCM</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fengxian District Hospital of TCM</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201400</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fang Fang, Master</last_name>
      <phone>+8613816856217</phone>
      <email>13816856217@139.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2016</study_first_submitted>
  <study_first_submitted_qc>October 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 18, 2016</study_first_posted>
  <last_update_submitted>December 18, 2017</last_update_submitted>
  <last_update_submitted_qc>December 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bronchial Asthma</keyword>
  <keyword>Traditional Chinese Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Through this study, to find the appropriate treatment of traditional Chinese medicine, then to further promote</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

